Multiple sclerosis (MS) is characterized clinically by episodes of relapsing or chronic paralysis and the pathogenesis is attributed to T-cell-mediated inflammation of the CNS. Clinical, histopathological and immunological similarities between MS and experimental autoimmune encephalomyelitis (EAE) allow EAE to be used as a model for therapeutic approaches to MS. Inhibition of murine relapsing EAE with multiple oral administrations of myelin basic protein (MBP) to BP10.PL mice has been reported recently. Two mechanisms have been proposed for MBP-induced oral tolerance - active suppression and clonal anergy/deletion. Deciphering mechanisms of oral tolerance to MBP and testing tolerizing strategies for protection from EAE have been facilitated by the development of MBP T-cell receptor (TCR) transgenic (Tg) mice. These mice express a TCR specific for the immunodominant MBP epitope (NAc 1-11) on 95% of their CD4+ T-cells and are highly susceptible to EAE. The investigator has preliminary data showing that orally administered MBP not only protects MBP TCR Tg mice from EAE but also induces a profound reduction of Tg+ cells from the periphery. This is followed by the return of a Tg population with decreased functional capacity. This evidence supports the investigator's hypothesis that high dose oral administration of an autoantigen induces early deletion of antigen-reactive cells, followed by a return to the periphery of autoantigen-reactive cells rendered anergic. The investigator proposes to address several questions pertaining to the mechanism and ideal conditions for MBP-induced oral tolerance. The investigator will differentiate between immediate trafficking or deletion of MBP-specific Tg cells after MBP feeding. She will characterize the duration of MBP-induced oral tolerance. She will optimize conditions for oral tolerance to MBP. Therefore, at their conclusion these studies will have 1) defined the effects of feeding antigen on antigen-specific T-cells and 2) optimized oral tolerance for application to a chronic inflammatory disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI043376-05
Application #
6510856
Study Section
Immunological Sciences Study Section (IMS)
Program Officer
Esch, Thomas R
Project Start
1998-07-01
Project End
2004-05-31
Budget Start
2002-06-01
Budget End
2004-05-31
Support Year
5
Fiscal Year
2002
Total Cost
$275,372
Indirect Cost
Name
Ohio State University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
098987217
City
Columbus
State
OH
Country
United States
Zip Code
43210
Smith, Kristen M; Guerau-de-Arellano, Mireia; Costinean, Stefan et al. (2012) miR-29ab1 deficiency identifies a negative feedback loop controlling Th1 bias that is dysregulated in multiple sclerosis. J Immunol 189:1567-76
Williams, Jessica L; Kithcart, Aaron P; Smith, Kristen M et al. (2011) Memory cells specific for myelin oligodendrocyte glycoprotein (MOG) govern the transfer of experimental autoimmune encephalomyelitis. J Neuroimmunol 234:84-92
Song, Fei; Wardrop, Richard M; Gienapp, Ingrid E et al. (2008) The Peyer's patch is a critical immunoregulatory site for mucosal tolerance in experimental autoimmune encephalomylelitis (EAE). J Autoimmun 30:230-7
McClain, Melanie A; Gatson, NaTosha N; Powell, Nicole D et al. (2007) Pregnancy suppresses experimental autoimmune encephalomyelitis through immunoregulatory cytokine production. J Immunol 179:8146-52
Powell, Nicole D; Papenfuss, Tracey L; McClain, Melanie A et al. (2005) Cutting edge: macrophage migration inhibitory factor is necessary for progression of experimental autoimmune encephalomyelitis. J Immunol 175:5611-4
Whitacre, Caroline C; Song, Fei; Wardrop 3rd, Richard M et al. (2004) Regulation of autoreactive T cell function by oral tolerance to self-antigens. Ann N Y Acad Sci 1029:172-9
Papenfuss, Tracey L; Rogers, Connie J; Gienapp, Ingrid et al. (2004) Sex differences in experimental autoimmune encephalomyelitis in multiple murine strains. J Neuroimmunol 150:59-69
Srinivasan, Mythily; Gienapp, Ingrid E; Stuckman, Scott S et al. (2002) Suppression of experimental autoimmune encephalomyelitis using peptide mimics of CD28. J Immunol 169:2180-8
Srinivasan, M; Wardrop, R M; Gienapp, I E et al. (2001) A retro-inverso peptide mimic of CD28 encompassing the MYPPPY motif adopts a polyproline type II helix and inhibits encephalitogenic T cells in vitro. J Immunol 167:578-85
Meyer, A L; Benson, J; Song, F et al. (2001) Rapid depletion of peripheral antigen-specific T cells in TCR-transgenic mice after oral administration of myelin basic protein. J Immunol 166:5773-81

Showing the most recent 10 out of 13 publications